Athira Pharma's fosgonimeton (ATH-1017), part of the same HGF/c-Met program, failed the primary endpoint of its Phase 2/3 LIFT-AD Alzheimer's trial in September 2024
Received: 13-Jul-2020 Published: 03-Apr-2021, DOI: 10.35248/2155-6156.21.12.869 Copyright: 2021 Wagih NF, et al
LUPKIN: Instead of trying to figure out how many customers were ordering doses, she decided to look further up the supply chain
For your own safety as a consumer, always verify that your provider sources medication from legitimate compounding pharmacies, and avoid purchasing from unregulated online sellers or international suppliers without medical supervision
The table below shows common similar side effects of Ozempic as well as Mounjaro 7 , 8 : Other rare but serious side effects of both these medications include: Also, semaglutide has been linked to a higher risk of worsening diabetic retinopathy 15